Correlation Between Malayan Banking and Duopharma Biotech

Can any of the company-specific risk be diversified away by investing in both Malayan Banking and Duopharma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Malayan Banking and Duopharma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Malayan Banking Bhd and Duopharma Biotech Bhd, you can compare the effects of market volatilities on Malayan Banking and Duopharma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Malayan Banking with a short position of Duopharma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Malayan Banking and Duopharma Biotech.

Diversification Opportunities for Malayan Banking and Duopharma Biotech

-0.31

Correlation Coefficient

Malayan Banking  Duopharma Biotech

Very good diversification

The 3 months correlation between Malayan and Duopharma is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Malayan Banking Bhd and Duopharma Biotech Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Duopharma Biotech Bhd and Malayan Banking is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Malayan Banking Bhd are associated (or correlated) with Duopharma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Duopharma Biotech Bhd has no effect on the direction of Malayan Banking i.e., Malayan Banking and Duopharma Biotech go up and down completely randomly.

Pair Corralation between Malayan Banking and Duopharma Biotech

Assuming the 90 days trading horizon Malayan Banking Bhd is expected to generate 0.52 times more return on investment than Duopharma Biotech. However, Malayan Banking Bhd is 1.92 times less risky than Duopharma Biotech. It trades about 0.04 of its potential returns per unit of risk. Duopharma Biotech Bhd is currently generating about -0.02 per unit of risk. If you would invest  993.00  in Malayan Banking Bhd on December 30, 2024 and sell it today you would earn a total of  19.00  from holding Malayan Banking Bhd or generate 1.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Malayan Banking Bhd  vs.  Duopharma Biotech Bhd

Malayan Banking Bhd

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Malayan Banking Bhd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Malayan Banking is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Duopharma Biotech Bhd

Risk-Adjusted Performance

Very Weak

Over the last 90 days Duopharma Biotech Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Malayan Banking and Duopharma Biotech

The main advantage of trading using opposite Malayan Banking and Duopharma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Malayan Banking position performs unexpectedly, Duopharma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Duopharma Biotech will offset losses from the drop in Duopharma Biotech's long position.

The idea behind Malayan Banking Bhd and Duopharma Biotech Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.